A1C is routinely used to monitor glycemic control for patients with diabetes. At the Scientific Sessions, Jay H. Shubrook, DO, FACOFP, FAAFP, BC-ADM, and David B. Sacks, MB ChB, FACP, FRCPath, debated whether point-of-care A1C should be part of the diagnostic toolkit for diabetes.

Marcela Brissova, PhD, Struan F.A. Grant, PhD, Maggie Ng, PhD, and Melina Claussnitzer, PhD, discussed how molecular and genetic studies are providing new insight into the influence of genetics in the development and progression of diabetes.

“The KPMP is all about using the kidney biopsy, which is an old tool, to understand kidney disease in a new way by almost turbocharging the information that we get,” said Jonathan Himmelfarb, MD.

New research uses single-cell technologies to explore the roles of adipocytes, macrophages, beta cells, and fibroblast growth factor-1 in metabolic tissue function. Qiong (Annabel) Wang, PhD, Christopher K. Glass, MD, PhD, Heiko Lickert, PhD, and Michael W. Schwartz, MD, reviewed this work at the Scientific Sessions.

Brian A. Ference, MD, MPhil, MSc, FACC, FESC, Lisa R. Tannock, MD, Jean-Claude Tardif, CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS, and Stephen G. Young, MD, discussed new insights into the role of triglycerides in cardiovascular disease at the Scientific Sessions.

A symposium sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases showcased current research by six young scientists—Emily K. Sims, MD, Emilyn U. Alejandro, PhD, Rafael Arrojo e Drigo, PhD, Camille E. Powe, MD, Rochelle N. Naylor, MD, and Joshua J. Joseph, MD, MPH, FAHA—aimed at developing a more stratified medical approach…

Patients have rallied behind the development of do-it-yourself automated insulin delivery systems to manage their diabetes. Natalie J. Bellini, MSN, FNP-BC, Dana Lewis, BA, Anna Norton, MS, and David M. Maahs, MD, PhD, discussed potential ramifications for patients, clinicians, researchers, and even manufacturers of commercial closed-loop devices.

“Equity is our goal,” said Tiffany L. Gary-Webb, PhD, MHS. “But the reality is right now we’re not anywhere near that. The reality is that some people have much more than they need and there are other people who are digging themselves out of a hole.”

Jonathan Z. Long, PhD, Yu-Hua Tseng, PhD, Kristin I. Stanford, PhD, and Anthony W. Ferrante, MD, PhD, discussed emerging understanding of how organ systems communicate to regulate and maintain energy homeostasis.

Recent and emerging research sheds new light on the role of beta cells in the development and progression of type 1 diabetes. Carmella Evans-Molina, MD, PhD, explained the association between beta cell function and immune therapy efficacy.